The present results, along with others previously published, demonstrate that the analysis of genes other than BRCA1/2 increases the detection rate of P/LP variants, which maximizes the identification of germline variants in patients with hereditary and unselected BC. This evidence concerns the gene BRCA1 and breast cancer.